Sitacure-M 50/500 is an oral antidiabetic combination containing Sitagliptin 50mg and Metformin Hydrochloride 500mg. It may be prescribed for adults with type 2 diabetes mellitus when combination therapy is considered appropriate. The two active ingredients have complementary actions that help support blood glucose regulation and improve glycaemic control. Its use should be based on the advice and supervision of a qualified healthcare professional. Effective type 2 diabetes mellitus management generally involves a combination of appropriate medication, a balanced diet, regular physical activity and monitoring of blood glucose levels. Sitacure-M 50/500 may be included in an individualized treatment plan when deemed suitable by a healthcare professional. Hertz Pharma provides pharmaceutical solutions such as Sitacure-M 50/500 to support diabetes care and responsible treatment.